Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosus
Clinical trial NCT02106897 · COMPLETED
Trial details
- NCT number
- NCT02106897
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-30
- Primary completion
- 2016-05-24
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.